Valuation Imexpharm Corporation

Stocks

End-of-day quote Ho Chi Minh S.E. Other stock markets 2026-07-28			5-day change	1st Jan Change
35,000.00 ^VND	0.00%		-2.78%	-33.33%

07-19	Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-01	Imexpharm Corporation Announces Cash Dividend for the Year 2025, Payable on July 21, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,390,314	-
Change	-	-22.62%	-1.28%	82.69%	11.7%	-33.33%	-
Enterprise Value (EV)	5,187,048	4,013,628	3,962,167	7,238,421	8,085,471	5,390,314	5,390,314
Change	-	-22.62%	-1.28%	82.69%	11.7%	-33.33%	0%
P/E	29.9x	17.2x	15.6x	24.3x	26.6x	15.2x	14x
PBR	2.89x	2.11x	1.9x	3.32x	-	2.15x	1.97x
PEG	-	0.5x	1.68x	1.4x	11.68x	0.9x	1.65x
Capitalization / Revenue	4.1x	2.44x	1.99x	3.28x	3.31x	2.03x	1.87x
EV / Revenue	0x	0x	0x	0x	0x	2.03x	1.87x
EV / EBITDA	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	11x	10.1x
EV / FCF	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-
Dividend per Share ²	649.4	-	-	500	-	1,000	1,000
Rate of return	1.93%	-	-	1.06%	-	2.86%	2.86%
EPS ²	1,126	1,513	1,653	1,932	1,976	2,304	2,499
Distribution rate	57.7%	-	-	25.9%	-	43.4%	40%
Net sales ¹	1,266,597	1,643,707	1,994,037	2,205,120	2,441,085	2,659,000	2,881,000
EBITDA	299,271	-	457,049	521,703	-	-	-
EBIT ¹	234,475	300,992	374,407	403,285	445,003	490,000	532,000
Net income ¹	189,095	233,964	299,556	320,862	349,138	394,000	428,000
Net Debt	-	-	-	-	-	-	-
Reference price ²	33,679.65	26,060.61	25,727.27	47,000.00	52,500.00	35,000.00	35,000.00
Nbr of stocks (in thousands)	154,011	154,011	154,007	154,009	154,009	154,009	-
Announcement Date	1/20/22	1/17/23	1/19/24	1/20/25	1/20/26	-	-

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IMEXPHARM CORPORATION	15.19x	-	-	-	205M
ELI LILLY AND COMPANY	36.25x	12.94x	27.18x	0.55%	1,089B
JOHNSON & JOHNSON	28.59x	6.53x	18.09x	2.01%	643B
ABBVIE INC.	33.13x	7.75x	15.94x	2.61%	465B
ROCHE HOLDING AG	20.2x	4.86x	12.04x	2.72%	359B
NOVARTIS AG	22.65x	5.84x	14.57x	2.74%	303B
ASTRAZENECA PLC	22.03x	4.53x	12.8x	1.93%	267B
NOVO NORDISK A/S	14.79x	5.48x	11.3x	3.38%	226B
AMGEN INC.	25.81x	6.73x	11.86x	2.57%	212B
GILEAD SCIENCES, INC.	-48.4x	5.8x	32.01x	2.45%	167B
Average	17.02x	6.72x	17.31x	2.33%	373.13B
Weighted average by Cap.	25.19x	8.11x	19.08x	1.92%